Is there a benefit forCYP2C19genotype-guided antiplatelet treatment in elderly acute coronary syndrome patients? / Wout WA van den Broek, Jurriën M ten Berg
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
Erscheinungsort nicht ermittelbar: 2021 |
| Enthalten in: |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
van den Broek, Wout WA [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Themen: |
Acute coronary syndrome |
|---|
| Umfang: |
1 Online-Ressource (4 p) |
|---|
| doi: |
10.2217/pgs-2021-0078 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
KFL011090944 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL011090944 | ||
| 003 | DE-627 | ||
| 005 | 20231109205956.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230609s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/pgs-2021-0078 |2 doi | |
| 035 | |a (DE-627)KFL011090944 | ||
| 035 | |a (KFL)prod_FICIBQ_10.2217/pgs-2021-0078 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a van den Broek, Wout WA |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Is there a benefit forCYP2C19genotype-guided antiplatelet treatment in elderly acute coronary syndrome patients? |c Wout WA van den Broek, Jurriën M ten Berg |
| 264 | 1 | |a [Erscheinungsort nicht ermittelbar] |c 2021 | |
| 300 | |a 1 Online-Ressource (4 p) | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 653 | |a acute coronary syndrome | ||
| 653 | |a CYP2C19 | ||
| 653 | |a dual antiplatelet therapy | ||
| 653 | |a elderly | ||
| 653 | |a P2Y12-inhibitor | ||
| 653 | |a pharmacogenetics | ||
| 700 | 1 | |a ten Berg, Jurriën M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacogenomics |d London [u.a.] : Ashley, 2000 |h Online-Ressource |w (DE-627)KFL00000605X |w (DE-600)2030168-6 |w (DE-576)398099871 |x 1744-8042 |7 nnns |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/future-medicine-ejournals-pharmazie/doi.org/10.2217/pgs-2021-0078 |m X:KFL |x Resolving-System |y FID Access |z lizenzpflichtig |
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 935 | |i IMPORT_0628_prod_FICIBQ_03 | ||
| 951 | |a AR | ||